<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03386734</url>
  </required_header>
  <id_info>
    <org_study_id>N/2016/72</org_study_id>
    <secondary_id>ENGOT-Cx4</secondary_id>
    <secondary_id>GINECO-CE106</secondary_id>
    <nct_id>NCT03386734</nct_id>
  </id_info>
  <brief_title>International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer</brief_title>
  <acronym>SENTICOLIII</acronym>
  <official_title>International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>ARCAGY/ GINECO GROUP</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>European Network of Gynaecological Oncological Trial Groups (ENGOT)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      SENTICOL III is large prospective multicenter international randomized study designed to
      validate the Sentinel Lymph Node (SLN) mapping technique in early cervical cancer. This
      &quot;validation study&quot; will compare the outcome of patients with negative SLN (experimental arm)
      vs patients with negative SLN + Pelvic Lymph Node dissection (PLN)(reference arm).

      There will be a &quot;quality assurance&quot; program which will be developed in participating centers
      with detailed requirements in terms of surgeons' qualifications, pathology qualification, SLN
      ultrastaging, standardization of the procedure, etc. as well as respect of the &quot;safety
      algorithm&quot;.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 3, 2018</start_date>
  <completion_date type="Anticipated">May 2026</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease Free Survival (DFS)</measure>
    <time_frame>Year 3</time_frame>
    <description>Composite outcome: the time interval between randomization and recurrence (local/distant) or second cancer or death (all causes), whichever occurs first.
This time interval will be analysed concomitantly with HR-QoL scores as a composite outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Health-related quality of life (HR-QoL)</measure>
    <time_frame>Year 3</time_frame>
    <description>Composite outcome: significant deterioration will specifically be assessed through 3 targeted dimensions (pain score, global health score and physical functioning scores) in EORTC QLQ-C30 and QLQ-CX24 questionnaires.
These scores will be analysed concomitantly with DFS as a composite outcome.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">950</enrollment>
  <condition>Cervical Cancer</condition>
  <arm_group>
    <arm_group_label>SLN biopsy only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Sentinel lymph node (SLN) biopsy only. A full lymphadenectomy will not be performed. The radical hysterectomy or trachelectomy will be done.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SLN biopsy + PLN dissection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SLN biopsy + full pelvic lymph node dissection (PLN) will be performed. The radical hysterectomy or trachelectomy will be done.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SLN biopsy only</intervention_name>
    <description>In experimental arm, SLN dissection only. A full lymphadenectomy will not be performed. The radical hysterectomy or trachelectomy will be done.</description>
    <arm_group_label>SLN biopsy only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>SLN biopsy + PLN dissection</intervention_name>
    <description>In active comparator arm, SLN dissection + full lymphadenectomy will be performed.</description>
    <arm_group_label>SLN biopsy + PLN dissection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  With squamous or adenocarcinoma of the cervix (proven by biopsy or cone biopsy),

          -  Stage Ia1 with lymphovascular emboli, Ia2, Ib1 and IIa1 (clinical stage) of the 2009
             FIGO classification,

          -  Maximum diameter ≤ 40 mm by clinical examination and magnetic resonance imaging (MRI),

          -  INo suspicious node on pelvic and abdominal MRI with an exploration up to the
             femoralleft renal vein (according to RECIST 1.1),

          -  Eastern Cooperative Oncology Group (ECOG) Performance status 0-2,

          -  Signed informed consent and ability to comply with follow-up,

          -  French subjects: in France, a subject will be eligible for inclusion in this study
             only if either affiliated to, or a beneficiary of, a social security category.

        Exclusion Criteria:

          -  Pregnancy,

          -  Previous pelvic or abdominal cancer,

          -  Previous chemotherapy and/or radiation therapy for the cervical cancer (previous
             brachytherapy is accepted),

          -  Proven allergy to blue dye, isotope or indocyanine green (ICG).
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabrice Lecuru, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital Européen Georges-Pompidou</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rachida Mama Abdou</last_name>
    <phone>0033184852016</phone>
    <email>rmamaabdou@arcagy.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kristina Mouyabi</last_name>
    <phone>0033381218356</phone>
    <email>kmouyabi@chu-besancon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de la Réunion</name>
      <address>
        <city>Saint-Denis</city>
        <state>La Réunion</state>
        <zip>97400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Anca Paula Birsan Frances, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU d'Amiens</name>
      <address>
        <city>Amiens</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Sergent, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Henri Duffaut</name>
      <address>
        <city>Avignon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laurène Lugans, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajeev Ramanah, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Bergonié</name>
      <address>
        <city>Bordeaux</city>
        <zip>33000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Guyon, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinique Tivoli-Ducos</name>
      <address>
        <city>Bordeaux</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie Richard, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Center de Lutte Contre le Cancer François Baclesse</name>
      <address>
        <city>Caen</city>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Martin-Françoise, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffaele Fauvet, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Antoine Béclère</name>
      <address>
        <city>Clamart</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Deffieux, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Lutte Contre le Cancer Jean Perrin</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Caroline Cornou, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand - Hôpital d'Estaing</name>
      <address>
        <city>Clermont-Ferrand</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bourdel Nicolas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHI de Créteil</name>
      <address>
        <city>Créteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyril Touboul, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Serge Douvier, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Bicêtre</name>
      <address>
        <city>Le Kremlin-Bicêtre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Perrine Capmas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Oscar Lambret</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Eric Leblanc, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Lille - Hôpital Jeanne de Flandre</name>
      <address>
        <city>Lille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Collinet, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Limoges</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tristan Gauthier, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupement Hospitalier Est - Hôpital Femme Mère Enfant</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gautier Chene, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Grand Hôpital de l'Est Francilien</name>
      <address>
        <city>Marne La Vallée</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Estelle Wafo, MD</last_name>
      <phone>0033 1 61 10 62 62</phone>
    </contact>
    <contact_backup>
      <last_name>Tchadie Bommenel</last_name>
      <email>tbommenel@ghef.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Estelle WAFO, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de la Conception</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aubert Agostini, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Saint-Joseph</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elisabeth Chereau-Ewald, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Paoli Calmettes</name>
      <address>
        <city>Marseille</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Lambaudie, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de Montpellier Val d'Aurelle</name>
      <address>
        <city>Montpellier</city>
        <zip>34000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pierre-Emmanuel Colombo, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Mulhouse - Hôpital du Hasenrain</name>
      <address>
        <city>Mulhouse</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ramzi Kacem, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de l'Ouest - Centre René Gauducheau</name>
      <address>
        <city>Nantes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cecile Loaëc, MD</last_name>
    </contact>
    <investigator>
      <last_name>Cecile Loaëc, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre de Lutte Contre le Cancer Antoine Lacassagne</name>
      <address>
        <city>Nice</city>
        <zip>06000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves Fouché, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Curie</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Virginie Fourchotte, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Diaconesses Croix Saint Simon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcos Ballester, MD, PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Bichat - Claude Bernard</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Koskas, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier la Pitié Salpêtrière</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Uzan, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Européen Georges Pompidou</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabrice Lécuru, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emile Darai, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>François Golfier, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hôpital de Poissy-Saint-Germain-en-Laye</name>
      <address>
        <city>Poissy</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cyrille Huchon, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Poitiers - Hôpital de la Milétrie</name>
      <address>
        <city>Poitiers</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cédric Nadeau, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Reims - Hôpital Robert Debré</name>
      <address>
        <city>Reims</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivier Graesslin, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hôpital Sud</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Lavoue, MD PhD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut Universitaire du Cancer de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gwenael Ferron, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Institut de Cancérologie de Lorraine</name>
      <address>
        <city>Vandoeuvre les nancy</city>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frédéric Marchal, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre de Lutte Contre le Cancer Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien Gouy, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>December 15, 2017</study_first_submitted>
  <study_first_submitted_qc>December 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 29, 2017</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

